{"text": "rt AT_USER survival from checkmate-067 (opdivo+yervoy in melanoma), via james larkin $bmy #aacr17 URL"}
{"text": "earlybird twitter approved for trade floors. $bmy gay talese, author of high notes, was interviewed on m... #markets URL"}
{"text": "rt AT_USER on the fly: top stock stories for monday $f $tsla $gm $pnra $fcau $tm $hpe $csc $dxc $nvcr $incy $bmy $acor $orly\u00a1\u00ad URL"}
{"text": "stocks going ex-dividend the first week of april URL $axp $bks $bmy $cmcsa $csco $dgx $gd $gis $gps $intu $jpm"}
{"text": "rt AT_USER survival from checkmate-067 (opdivo+yervoy in melanoma), via james larkin $bmy #aacr17 URL"}
{"text": "AT_USER AT_USER note $mrk 2 yr exclusivity was limited to pivotal trials in adv/met melanoma. nothing circumvented with $bmy deal."}
{"text": "rt AT_USER $bmy makes survival in melanoma combo trial. $mrk, #aacr17 URL"}
{"text": "rt AT_USER survival from checkmate-067 (opdivo+yervoy in melanoma), via james larkin $bmy #aacr17 URL"}
{"text": "$bmy checkmate143 - did not meet primary endpoint of improved overall survival over bevacizumab monotherapy.\u00a1\u00ad URL"}
{"text": "#bristolmyerssquibb bristol-myers squibb release: five-year survival observed with opdivo (n... read more: URL $bmy"}
{"text": "#bristolmyerssquibb bristol-myers squibb release: five-year survival observed with opdivo (n... read more: URL $bmy"}
{"text": "#bristolmyerssquibb fiveyear survival observed with opdivo nivolumab in patients with previo... read more: URL $bmy"}
{"text": "#bristolmyerssquibb fiveyear survival observed with opdivo nivolumab in patients with previo... read more: URL $bmy"}
{"text": "must read: up today on news. short squeeze coming: URL $bmy $nxpi $mbly $mar $idu $hban $mpw $emes $intu $tgp"}
{"text": "#bristolmyerssquibb b-ms hails new 'landmark' opdivo data. read more: URL $bmy"}
{"text": "#bristolmyerssquibb b-ms hails new 'landmark' opdivo data. read more: URL $bmy"}
{"text": "bristol-myers (bmy), incyte to advance clinical program URL $bmy $incy"}
{"text": "rt AT_USER 5yr follow-up from ca209-003 study of opdivo in 2l nsclc, via julie brahmer $bmy #aacr17 URL"}
{"text": "rt AT_USER prices of new, advanced cancer drugs soaring through the roof $bmy, $mrk stockmarket: URL URL"}
{"text": "rt AT_USER 5 things for #pharma #marketers to know:mon, apr 3 $bmy #immunotherapy #cancer #oncology $myl #epipen $biib $fwp #ms URL"}
{"text": "5 things for #pharma #marketers to know:mon, apr 3 $bmy #immunotherapy #cancer #oncology $myl #epipen $biib $fwp\u00a1\u00ad URL"}
{"text": "bristol-myers' opdivo fails to beat roche's avastin in late-stage brain cancer study $bmy $rhhby URL"}
{"text": "rt AT_USER survival from checkmate-067 (opdivo+yervoy in melanoma), via james larkin $bmy #aacr17 URL"}
{"text": "on the fly: top stock stories for monday $f $tsla $gm $pnra $fcau $tm $hpe $csc $dxc $nvcr $incy $bmy $acor $orly\u00a1\u00ad URL"}
{"text": "rt AT_USER survival from checkmate-067 (opdivo+yervoy in melanoma), via james larkin $bmy #aacr17 URL"}
{"text": "rt AT_USER survival from checkmate-067 (opdivo+yervoy in melanoma), via james larkin $bmy #aacr17 URL"}
{"text": "rt AT_USER 5yr follow-up from ca209-003 study of opdivo in 2l nsclc, via julie brahmer $bmy #aacr17 URL"}
{"text": "rt AT_USER $bmy  - #fail - announces results from checkmate -143, a phase 3 study of opdivo (nivolumab) in patients with glioblastoma mu\u00a1\u00ad"}
{"text": "#bristolmyerssquibb brief-bristol-myers says opdivo in combination with yervoy and opdivo mo... read more: URL $bmy"}
{"text": "#bristolmyerssquibb brief-bristol-myers says opdivo in combination with yervoy and opdivo mo... read more: URL $bmy"}
{"text": "#bristolmyerssquibb opdivo nivolumab in combination with yervoy ipilimumab and opdivo monoth... read more: URL $bmy"}
{"text": "#bristolmyerssquibb opdivo nivolumab in combination with yervoy ipilimumab and opdivo monoth... read more: URL $bmy"}
{"text": "rt AT_USER $bmy  - #fail - announces results from checkmate -143, a phase 3 study of opdivo (nivolumab) in patients with glioblastoma mu\u00a1\u00ad"}
{"text": "rt AT_USER survival from checkmate-067 (opdivo+yervoy in melanoma), via james larkin $bmy #aacr17 URL"}
{"text": "rt AT_USER survival from checkmate-067 (opdivo+yervoy in melanoma), via james larkin $bmy #aacr17 URL"}
{"text": "rt AT_USER survival from checkmate-067 (opdivo+yervoy in melanoma), via james larkin $bmy #aacr17 URL"}
{"text": "prices of new, advanced cancer drugs soaring through the roof $bmy, $mrk stockmarket: URL URL"}
{"text": "rt AT_USER survival from checkmate-067 (opdivo+yervoy in melanoma), via james larkin $bmy #aacr17 URL"}
{"text": "$bmy $fprx URL"}
{"text": "racing in #lungcancer again (or still), $mrk &amp; $bmy expand $incy combo trials URL"}
{"text": "$incy $bmy  plans to initiate phase 3 registrational trials with $incy ido inhibitor, epacadostat, and  $bmy' opdivo in first-line nsclc"}
{"text": "rt AT_USER survival from checkmate-067 (opdivo+yervoy in melanoma), via james larkin $bmy #aacr17 URL"}
{"text": "$bmy #immunotherapy combination extends survival in #melanoma URL #aacr17 #melsm"}
{"text": "rt AT_USER 5yr follow-up from ca209-003 study of opdivo in 2l nsclc, via julie brahmer $bmy #aacr17 URL"}
{"text": "rt AT_USER incyte dramatically ups the immuno-oncology combo ante URL $incy $mrk $bmy URL"}
{"text": "#aacr17 roundup: $bmy, $mrk and $pfe in the spotlight, marking progress with checkpoints URL #immunotherapy"}
{"text": "rt AT_USER survival from checkmate-067 (opdivo+yervoy in melanoma), via james larkin $bmy #aacr17 URL"}
{"text": "incyte dramatically ups the immuno-oncology combo ante URL $mrk $bmy $azn $rhhby $incy"}
{"text": "incyte dramatically ups the immuno-oncology combo ante URL $mrk $bmy $azn $rhhby $incy"}
{"text": "incyte dramatically ups the immuno-oncology combo ante URL $mrk $bmy $azn $rhhby $incy"}
{"text": "bristol-myers squibb $bmy who? why pfizer $pfe could be making googly eyes at this michigan biotech instead\u00a1\u00ad URL"}
{"text": "bristol-myers squibb co $bmy stake decreased by gamco investors inc. et al URL"}
{"text": "bristol-myers squibb co $bmy stake increased by asset management one co. ltd. URL"}
{"text": "bottom of today's range: $bx $infy $mt $nly 0, $alxn $cost 1, $anf $lulu $vrx 2, $cvs $gild $mat 3, $agn $bmy $lb $mnk $nuan $trip $wmt 4"}
{"text": "$bmy fib retracement 53.75ish"}
{"text": "AT_USER bristol-myers' opdivo fails to beat roche's avastin in late-stage brain cancer study URL $bmy, $rhhby"}
{"text": "bristol-myers' opdivo fails to beat roche's avastin in late-stage brain cancer study URL $bmy $rhhby"}
{"text": "$bmy nasty reversal! looks like we're going much lower, some bad n good news and clearly bad always weighs more...53 here we come"}
{"text": "rt AT_USER on the fly: top stock stories at midday $f $gm $tsla $fcau $tm $hpe $csc $dxc $nvcr $incy $bmy $acor $orly $kmx URL"}
{"text": "on the fly: top stock stories at midday $f $gm $tsla $fcau $tm $hpe $csc $dxc $nvcr $incy $bmy $acor $orly $kmx URL"}
{"text": "rt AT_USER $bmy makes survival in melanoma combo trial. $mrk, #aacr17 URL"}
{"text": "$bmy nivolumab fails in phase 3 trial of glioblostama multiforme. URL"}
{"text": "rt AT_USER incyte dramatically ups the immuno-oncology combo ante URL $incy $mrk $bmy URL"}
{"text": "bristol-myers' opdivo fails to beat roche's avastin in late-stage brain cancer study URL $bmy $rhhby"}
{"text": "bristol-myers' opdivo fails to beat roche's avastin in late-stage brain cancer study URL $bmy $rhhby"}
{"text": "time to open the $bmy trap door"}
{"text": "bristol \"can't afford to lose to\" dow stock merck in immuno-oncology $bmy $mrk $incy $azn  URL"}
{"text": "rt AT_USER $bmy  - #fail - announces results from checkmate -143, a phase 3 study of opdivo (nivolumab) in patients with glioblastoma mu\u00a1\u00ad"}
{"text": "rt AT_USER $bmy makes survival in melanoma combo trial. $mrk, #aacr17 URL"}
{"text": "#bristolmyerssquibb racing in lung cancer again (or still), merck and bms expand incyte comb... read more: URL $bmy"}
{"text": "#bristolmyerssquibb racing in lung cancer again (or still), merck and bms expand incyte comb... read more: URL $bmy"}
{"text": "rt AT_USER 5yr follow-up from ca209-003 study of opdivo in 2l nsclc, via julie brahmer $bmy #aacr17 URL"}
{"text": "rt AT_USER survival from checkmate-067 (opdivo+yervoy in melanoma), via james larkin $bmy #aacr17 URL"}
{"text": "rt AT_USER incyte dramatically ups the immuno-oncology combo ante URL $incy $mrk $bmy URL"}
{"text": "racing in #lungcancer again (or still), $mrk and $bmy expand $incy combo trials URL"}
{"text": "rt AT_USER incyte dramatically ups the immuno-oncology combo ante URL $incy $mrk $bmy URL"}
{"text": "rt AT_USER 5yr follow-up from ca209-003 study of opdivo in 2l nsclc, via julie brahmer $bmy #aacr17 URL"}
{"text": "#bristolmyerssquibb pursuing equity ihi brings together leading health care organizations fo... read more: URL $bmy"}
{"text": "#bristolmyerssquibb pursuing equity ihi brings together leading health care organizations fo... read more: URL $bmy"}
{"text": "#bristolmyerssquibb pursuing equity: ihi brings together leading health care organizations f... read more: URL $bmy"}
{"text": "#bristolmyerssquibb pursuing equity: ihi brings together leading health care organizations f... read more: URL $bmy"}
{"text": "#aacr17 roundup: $bmy, merck kgaa &amp; $pfe in the spotlight, marking progress with checkpoints - URL"}
{"text": "#aacr17 fresh from $mrk embrace, fast-growing $incy pivots into a phiii ido1/ #opdivo tie-up with $bmy - URL"}
{"text": "love the institutional ownership. following big $$ works well.  $bmr $bmrc $bmrn $bms $bmtc $bmy URL"}
{"text": "rt AT_USER 5yr follow-up from ca209-003 study of opdivo in 2l nsclc, via julie brahmer $bmy #aacr17 URL"}
{"text": "incyte dramatically ups the immuno-oncology combo ante URL $incy $mrk $bmy URL"}
{"text": "rt AT_USER survival from checkmate-067 (opdivo+yervoy in melanoma), via james larkin $bmy #aacr17 URL"}
{"text": "rt AT_USER alan korman echoing jim allison's remark about lack of evidence of treg biology in anti-ctla4 treated humans i.e. #notmice\u00a1\u00ad"}
{"text": "s&amp;p100 #stocks performance $gd $amgn $msft $nee $rtn $bmy $celg $cat $fdx $jnj $pcln $mdt $dis $agn $intc  more@ URL"}
{"text": "rt AT_USER survival from checkmate-067 (opdivo+yervoy in melanoma), via james larkin $bmy #aacr17 URL"}
{"text": "wondering about risks of $bmy? the 63-day volatility is 16.67% URL"}
{"text": "rt AT_USER new data shows a $bmy drug combo works better for melanoma patients than one drug alone: URL by AT_USER"}
{"text": "bmy +0.54 total advance today 10:30 et. bristol-myers squibb company $bmy 54.92 stock hit a high of 55.15 and  URL"}
{"text": "$icnb-iconic-brands-wow-selling-wine-30-states-now-confirmed! $vapi $kays $blozf $pg $mrk $myl $vrx $vrtx $biib\u00a1\u00ad URL"}
{"text": "for $bmy, a victory and a mystery URL"}
{"text": "$bmy reports opdivo trial in gbm did not meet primary endpoint URL"}
{"text": "rt AT_USER eliquis smashes rivals xarelto, pradaxa at cutting bleed-related costs in real-world study URL $pfe $\u00a1\u00ad"}
{"text": "#bristolmyerssquibb bristol-myers squibb says cancer drug combination 'significantly' improv... read more: URL $bmy"}
{"text": "#bristolmyerssquibb bristol-myers squibb says cancer drug combination 'significantly' improv... read more: URL $bmy"}
{"text": "rt AT_USER 5yr follow-up from ca209-003 study of opdivo in 2l nsclc, via julie brahmer $bmy #aacr17 URL"}
